Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulgent Genetics Inc.

18.37
-0.0400-0.22%
Post-market: 18.26-0.1100-0.60%17:33 EDT
Volume:287.47K
Turnover:5.28M
Market Cap:559.25M
PE:-13.74
High:18.60
Open:18.37
Low:18.11
Close:18.41
Loading ...

Fulgent Genetics Secures EU CE Mark for Comprehensive Germline NGS Test, Expanding Diagnostic Reach Across Europe

Reuters
·
17 Jul

Press Release: Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025

Dow Jones
·
11 Jul

Chief Scientific Officer Hanlin Gao Reports Disposal of Common Shares in Fulgent Genetics Inc

Reuters
·
04 Jun

Chief Scientific Officer Hanlin Gao Reports Disposal of Fulgent Genetics Inc. Common Shares

Reuters
·
29 May

Fulgent Genetics Inc. Conducted Annual Stockholders Meeting

Reuters
·
16 May

Fulgent Genetics Is Maintained at Neutral by Piper Sandler

Dow Jones
·
07 May

Fulgent Genetics Price Target Raised to $25.00/Share From $24.00 by Raymond James

Dow Jones
·
05 May

Fulgent Genetics Inc : Raymond James Raises Target Price to $25 From $24

THOMSON REUTERS
·
05 May

Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges

GuruFocus.com
·
03 May

Fulgent Genetics Inc. Releases Transcript for Q1 2025 Earnings Call Event

Reuters
·
03 May

Fulgent Genetics Up Nearly 13%, on Pace for Largest Percent Increase Since November 2023 -- Data Talk

Dow Jones
·
02 May

Fulgent Genetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates

Zacks
·
02 May

BRIEF-Fulgent Genetics Q1 Revenue USD 73.463 Million

Reuters
·
02 May

Fulgent Genetics Reports Q1 2025: Sales Up 16%, Posts GAAP Loss of $11.5M, EPS at ($0.37)

Reuters
·
02 May

Fulgent Genetics Q1 Operating Expenses USD 48.141 Million

THOMSON REUTERS
·
02 May

Fulgent Genetics Inc - Expects 2025 Non-Gaap Loss of Approximately $0.65 per Share

THOMSON REUTERS
·
02 May

Fulgent Genetics Inc - Q1 Non-Gaap Income of $1.2 Million, or $0.04 per Share

THOMSON REUTERS
·
02 May

Fulgent Genetics Inc - Reiterates 2025 Core Revenue Guidance of $310 Million

THOMSON REUTERS
·
02 May

Fulgent Genetics Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
30 Apr